The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients

Bogdan Balas, Muhammad R. Baig, Catherine Watson, Beth E. Dunning, Monica Ligueros-Saylan, Yibin Wang, Yan Ling He, Celia Darland, Jens J. Holst, Carolyn F. Deacon, Kenneth Cusi, Andrea Mari, James E. Foley, Ralph A. DeFronzo

Research output: Contribution to journal › Article › peer-review

207 Scopus citations

Fingerprint

Dive into the research topics of 'The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences